Adam Mor
Division of Rheumatology
Department of Medicine
New York University School of Medicine
Hospital for Joint Diseases
USA
Name/email consistency: high
- Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic. Mor, A., Bingham, C.O., Kishimoto, M., Izmirly, P.M., Greenberg, J.D., Reddy, S., Rosenthal, P.B. Ann. Rheum. Dis. (2008)
- Drug-induced arthritic and connective tissue disorders. Mor, A., Pillinger, M.H., Wortmann, R.L., Mitnick, H.J. Semin. Arthritis Rheum. (2008)
- The role of Ras signaling in lupus T lymphocytes: biology and pathogenesis. Mor, A., Philips, M.R., Pillinger, M.H. Clin. Immunol. (2007)
- Familial Mediterranean fever successfully treated with etanercept. Mor, A., Pillinger, M.H., Kishimoto, M., Abeles, A.M., Livneh, A. J. Clin. Rheumatol (2007)
- Compartmentalized Ras/MAPK signaling. Mor, A., Philips, M.R. Annu. Rev. Immunol. (2006)
- Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. Mor, A., Mitnick, H.J., Greene, J.B., Azar, N., Budnah, R., Fetto, J. J. Clin. Rheumatol (2006)
- Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. Mor, A., Bingham, C., Barisoni, L., Lydon, E., Belmont, H.M. J. Rheumatol. (2005)